2005
DOI: 10.1016/j.ejrad.2004.10.007
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of transjugular intrahepatic portosystemic shunt dysfunction in PTFE-covered stent-grafts versus bare stents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
73
1
4

Year Published

2009
2009
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 97 publications
(83 citation statements)
references
References 23 publications
5
73
1
4
Order By: Relevance
“…Dedicated ePTFE-covered stents should be preferred over bare stents in order to reduce the risk of shunt dysfunction (1b, A) [18][19][20][29][30][31].…”
Section: Which Types Of Device Are Available For Tips?mentioning
confidence: 99%
See 1 more Smart Citation
“…Dedicated ePTFE-covered stents should be preferred over bare stents in order to reduce the risk of shunt dysfunction (1b, A) [18][19][20][29][30][31].…”
Section: Which Types Of Device Are Available For Tips?mentioning
confidence: 99%
“…Comment: Two RCTS [32,33] and a meta-analysis [29] of six studies (one prospective and five retrospective) comparing TIPS placement with PTFE-covered stents and bare stents for portal hypertension related complications showed that the covered stent was superior in terms of shunt dysfunction (HR = 0.28; 95% CI 0.20-0.35).…”
Section: Which Types Of Device Are Available For Tips?mentioning
confidence: 99%
“…Accordingly, understanding the predisposing factors leading to TIPS dysfunction and efforts to solve those problems are necessary to maintain long-term patency after TIPS placement. Currently, the best solution for TIPS dysfunction seems to be the use of polytetrafluoroethylene-covered stent grafts that isolate blood from hepatic tissue, therefore blocking the tentative triggering mechanisms of pseudointimal and intimal hyperplasia or thrombosis (19)(20)(21)(22)(23)(24)(25)(26)(27). Recently, a meta-analysis of six studies demonstrated not only a significant improvement of primary patency (hazard ratio [HR], 0.28) and a significant reduction of risk of hepatic encephalopathy (HR, 0.65), but also a significant decrease of mortality in the covered-stent group (HR, 0.76) (25).…”
Section: Discussionmentioning
confidence: 99%
“…Among many theories, widely accepted ones are thrombosis, pseudointimal hyperplasia caused by bile leaks of transected bile ducts into the stent lumen, and intimal hyperplasia of the hepatic vein outflow tract (16)(17)(18). Recently, use of polytetrafluoroethylene (PTFE)-covered stents has decreased TIPS dysfunction by allowing endoluminal endothelial lining and preventing bile leak into the stent (19)(20)(21)(22)(23)(24)(25)(26)(27).…”
Section: Introductionmentioning
confidence: 99%
“…Die Stentdysfunktion ist eine der häufigsten Komplikationen im Therapieverlauf nach TIPSImplantation (Barrio et al 2005, Boyer et al 2005 (Bilbao et al 2002). Andere Studien hatten Stenoseraten der implantierten Stents zwischen 22 % und 60 % (Crenshaw et al 1996, Nazarian et al 1997, Ochs et al 1995.…”
Section: Revisionenunclassified